Brief: Onxeo Launches Capital Increase Of Target Eur 9.3 Mln

Valerio Therapeutics SA

10/03/2021 18:23

March 10 (Reuters) - Onxeo SA  ALONX.PA :
    * LAUNCHES A CAPITAL INCREASE WITH PREFERENTIAL SUBSCRIPTION
RIGHTS FOR SHAREHOLDERS TO ACCELERATE ITS RESEARCH AND
DEVELOPMENT PROGRAMMES
    * TARGET AMOUNT OF €9.3M, WHICH MAY BE INCREASED TO €10.7M
BY
EXERCISE OF THE EXTENSION CLAUSE
    * SUBSCRIPTION PERIOD FROM 19 MARCH TO 31 MARCH 2021
INCLUSIVE IN
FRANCE AND FROM 19 MARCH TO 26 MARCH 2021 INCLUSIVE IN DENMARK
    * THIS TRANSACTION WILL SECURE THE FINANCING OF THE STRATEGY
AND
THE RESOURCES NECESSARY TO ACHIEVE KEY CLINICAL MILESTONES UNTIL
AT LEAST Q4 2022
    * SUBSCRIPTION PRICE: €0.71

Source text for Eikon:  ID:nBw7z0Jcxa 
Further company coverage:  ALONX.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))